 |
|
 |
 |
 |
- Accommodation
- Travel
- Optional Tour & Social Event Program
- Accompanying Persons Program
- Vancouver Convention Centre
- Related Meetings
- E-Newsletter Archives
Thank you to
our sponsors
Platinum Sponsor
In Association with
Program Highlights
Meet with the world’s leading scientific and medical specialists to address the current state of knowledge and research in Cardiovascular Health at ISH 2010.
ISH 2010 will have three program tracks: Basic Science, Clinical Science and Public Health/Population Science. We are pleased to highlight the following symposium presenters, from different parts of the world, who will speak on exciting topics of recent interest.
Click on the links below to go directly to any of the following sections:
For additional program information, please click here.
Basic Science
Rapid Steroid Signaling Pathways:
Dr. Ross Feldman, RW Gunton Professor of Therapeutics, Departments of Medicine and of Physiology & Pharmacology, The University of Western Ontario, Canada
“Choreographing the Rapid Vascular Effects of Steroids: Sorting out the Partners and the Steps”
Dr. John Funder, Department of Medicine, Monash University, Australia
“Reconsidering the Roles of the Mineralocorticoid Receptor”
Dr. Fredrik Leeb-Lundberg, Lund University in Sweden
“Rapid Steroid Effects in Hypertension: Role of GPR30”
 |
 |
 |
| Dr. Ross Feldman | Dr. John Funder | Dr. Fredrik Leeb-Lundberg |
Lipid Signaling in Vacular Disease (Focus on Sphingolipids):
Prof. Sarah Spiegel, Virginia Commonwealth University, USA
“Overview of Sphingolipid Signalling (Ceramide and Sphingosine)”
Prof. Markus van der Giet, Universitätsmedizin Berlin, Germany
“Relevance and Potential of Sphingosine-1-Phosphate for the Vascular System”
Prof. Steffen Bolz, University of Toronto, Canada
“Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone”
 |
 |
 |
| Prof. Sarah Spiegel | Prof. Markus van der Giet | Prof. Steffen Bolz |
Vascular Aging:
Prof. Edward Lakatta, National Institutes of Health, USA
“Molecular Mechanisms of Cardiac and Vascular Aging”
Prof. Geoffrey Pickering, Robarts Research Institute, University of Western Ontario, Canada
“Cellular Enzymes Regulating Lifespan: Implications for Prevention of Vascular Disease”
Prof. Abraham Aviv, the Center of Human Development and Aging UMDNJ, New Jersey Medical School, USA
“Teleomere Length and Hypertension and Vascular Disease”
 |
 |
 |
| Prof. Edward Lakatta | Prof. Geoffrey Pickering | Prof. Abraham Aviv |
Clinical Science
Dietary Approaches in Management of Cardiovascular Risk:
Prof. Lawrence Appel, Johns Hopkins Medical Institutions, USA
“Dietary Approaches to Prevent and Treat Hypertension”
Prof. Susan Barr, University of British Columbia, Canada
“Value, Utility and Limitations of Food Guides in Attaining Cardiovascular Health”
 |
 |
| Prof. Lawrence Appel | Prof. Susan Barr |
Hypertension in the Elderly
Prof. Liu Lisheng, President, World Hypertension League & Chinese Hypertension League, Cardiovascular Institute and Fu Wai Hospital, China
“Hypertension in the Elderly: Overview”
Prof. Raymond Townsend, Director, Hypertension Program, Hospital of the University of Pennsylvania, USA
“Hypertension in the Elderly: Considerations of arterial compliance and consequences on the kidney“
Prof. Chris Bulpitt, Hammersmith Hospital, United Kingdom
“What is the Threshold and Target for Treatment of hypertension in the elderly?”
 |
 |
 |
| Prof. Liu Lisheng | Prof. Raymond Townsend | Prof. Chris Bulpitt |
Public Health/Population Science
This section will be updated as information becomes available.
